首頁 > 市場調查報告書 > 醫療設備

心血管設備

市場調查報告書

商品編碼

1739529

全球植入式心臟整流去顫器市場規模（按類型、應用、最終用戶、區域範圍和預測）

Global Implantable Cardioverter Defibrillators Market Size By Type, By Application, By End-user, By Geographic Scope And Forecast

出版日期: 2025年05月09日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

植入式心臟整流去顫器市場規模及預測

植入式心臟整流去顫器(ICD) 市場規模預計在 2024 年達到 98.8 億美元，到 2032 年將達到 129.2 億美元，2026 年至 2032 年的複合年成長率為 3.41%。

植入式心臟整流去顫器是一種小型電子設備，通常植入在靠近鎖骨的皮膚下。它可以監測心律，並在檢測到異常心率（心律不整）時發出電擊。

ICD 持續監測心臟，並在發生危險的心律不整時發出電擊以恢復正常心律。典型的 ICD 由脈衝產生器和一根或多根向心臟發出電擊的導線組成。

ICD 適用於有危及生命的心律不整風險的患者，例如有心臟麻痹、心室顫動或某些類型心臟衰竭病史的患者。

植入通常在局部麻醉下進行，導線放置在心室內，脈衝產生器放置在皮膚下。

ICD 持續監測您的心律並記錄心律不整發作的數據。技術的進步使 ICD 體積更小、更強大，診斷能力更強，電池壽命也更長。

當 ICD 檢測到危及生命的心律不整（例如心室心搏過速或室性顫動）時，它會向心臟發出高能量電擊以恢復其正常節律。

一些 ICD 還具有心律調節器功能，這意味著它們可以根據需要發出起搏脈衝以維持適當的心率。

現代 ICD 提供遠端監控功能，使醫療保健提供者能夠遠端監控患者的心律和設備功能，從而可以更早發現潛在問題並減少頻繁就醫的需要。

全球植入式心臟整流去顫器市場動態

影響全球植入式心臟整流去顫器市場的關鍵市場動態為：

關鍵市場促進因素

心血管疾病發生率不斷上升：心血管疾病（包括心臟衰竭和心律不整）的發生率不斷上升，是導致心血管疾病發生率上升的關鍵因素。隨著這些疾病持續影響全球大量人口，對植入式心臟復律去顫器（ICD）作為救生設備的需求也在增加。

技術進步：ICD技術的不斷進步，例如小型化、更長的電池壽命、更強的診斷能力以及改進的心律不整檢測演算法，正在推動市場成長。這些技術創新提高了設備的功效和患者的治療效果。

人口老化加劇：人口老化導致心臟病發生率上升。老年人更容易出現心律不整和心臟驟停，這增加了對用於治療這些疾病的植入式心臟麻痹顫器（ICD）的需求。

意識提升與醫療基礎建設：已開發國家和開發中國家對心臟健康的認知不斷提高，以及先進醫療基礎設施的建設，推動ICD的廣泛應用。醫療服務可近性的改善也推動了透過ICD植入實現更早的診斷和治療。

監管支持和報銷政策：許多國家都制定了法律規範和報銷政策，以促進獲得 ICD 治療，鼓勵醫療保健提供者分發 ICD 並鼓勵患者接受 ICD 植入手術，從而促進市場成長。

生活方式的改變和風險因素：久坐不動、不健康飲食和高壓力等生活方式的改變，導致心血管疾病的發生率上升。這些生活方式的改變增加了心律不整和心臟疾病的風險，從而推動了對植入式心臟復律去顫器（ICD）作為預防和治療性介入的需求。

技術整合與遠端監控：植入式心臟復律去顫器 (ICD) 與無線連接和遠端監控系統等先進技術的整合，正在改善患者管理並提升療效。這些功能使醫療保健提供者能夠遠端監控患者的心臟健康狀況，確保及時干預，並降低頻繁就診帶來的醫療成本。

主要問題

高成本：ICD 設備和植入手術費用昂貴，限制了低收入患者和預算受限的醫療保健系統獲得治療的機會。

技術複雜性：儘管技術進步，但 ICD 仍然很複雜，需要接受植入和管理方面的專門培訓，這給醫療保健專業人員帶來了挑戰，並增加了程序風險。

裝置併發症：ICD 可能出現併發症，包括導線脫落、植入部位感染和裝置故障。這些問題可能導致需要額外手術，影響患者預後，並增加醫療成本。

電池壽命和更換：儘管電池技術已經改進，但由於電池磨損，ICD 仍然需要定期更換，這需要進行手術並伴隨相關風險和費用。

患者的選擇和管理選擇合適的 ICD 植入候選人並在植入後管理患者需要仔細評估風險和益處。年齡、合併症和生活方式選擇等因素會影響患者的治療結果和設備的有效性。

監管挑戰：滿足監管要求並確保符合不斷發展的標準，對製造商和醫療保健提供者而言是一項挑戰。法律規範的變化可能會影響器械核准和打入市場策略。

道德考量：對於植入裝置來管理危及生命的狀況的患者，在適當的選擇、同意和臨終關懷決策方面可能會出現道德困境。

競爭與市場動態：設備製造商之間的激烈競爭，加上某些地區的市場飽和，可能迫使公司在管理價格和市場佔有率的同時不斷創新。

主要趨勢

技術進步：ICD 技術的持續創新包括小型化、延長電池壽命、先進的心律不整檢測演算法以及與數位健康平台的整合，以實現遠端監控和患者管理。

轉向皮下植入式心臟復律去顫器 (S-ICD)：S-ICD 無需將導線插入心臟，從而降低了經靜脈導線相關併發症的風險。 S-ICD 為血管通路受限或感染疾病風險高的患者提供了一種替代方案。

個人化醫療：人們對個人化醫療的日益關注推動了基於患者特定因素（例如心率模式、潛在醫療狀況和生活方式）的 ICD 治療客製化。

遠端監控和增強連接性：ICD 與無線和行動技術的整合，實現了對心律和設備功能的即時遠端監控。這一趨勢有助於更早發現心律不整並主動管理設備相關問題，從而改善患者照護。

人口老化加劇：人口結構向老化轉變導致心血管疾病和心律不整發病率上升，從而增加了對 ICD 作為預防和治療解決方案的需求。

適應症擴大：ICD治療適應症由傳統的一級、二級預防擴大至缺血性心肌病變及某些遺傳性心律不整症候群的高風險患者，將增加市場潛力。

關注患者結果：專注於透過綜合護理途徑改善患者結果，包括患者教育、生活方式改變和心血管健康綜合管理以及 ICD 治療。

監管和報銷情勢：不斷變化的法律規範和報銷政策將影響市場動態，影響各地區的設備核准、市場進入和採用率。

ICDs continuously monitor heart rhythms and record data on arrhythmia episodes, which can be reviewed by healthcare providers during follow-up visits. Technological advancements have led to smaller, more sophisticated ICDs with enhanced diagnostic capabilities and longer battery life, improving patient outcomes and quality of life.

ICDs deliver high-energy shocks to the heart when they detect life-threatening arrhythmias like ventricular tachycardia or fibrillation, restoring the heart's normal rhythm.

Some ICD models also include pacemaker functionality, capable of delivering pacing pulses to maintain appropriate heart rates when needed.

Modern ICDs feature remote monitoring capabilities, allowing healthcare providers to monitor patients' heart rhythms and device function remotely, enabling early detection of potential issues and reducing the need for frequent clinic visits.

Global Implantable Cardioverter Defibrillators Market Dynamics

The key market dynamics that are shaping the global implantable cardioverter defibrillators market include:

Key Market Drivers

Increasing Incidence of Cardiovascular Diseases: The rising prevalence of cardiovascular diseases, including heart failure and arrhythmias, is a significant driver. As these conditions continue to affect a larger population globally, the demand for ICDs as life-saving devices also increases.

Advancements in Technology: Continuous advancements in ICD technology, such as miniaturization, longer battery life, enhanced diagnostic capabilities, and improved algorithms for arrhythmia detection, drive market growth. These innovations improve device effectiveness and patient outcomes.

Growing Aging Population: The demographic shift towards an aging population is contributing to higher incidences of heart diseases. Elderly individuals are more prone to arrhythmias and sudden cardiac arrest, thereby increasing the demand for ICDs to manage these conditions.

Expanding Awareness and Healthcare Infrastructure: Increasing awareness about cardiac health and the availability of advanced healthcare infrastructure in developed and developing countries are driving the adoption of ICDs. Improved access to healthcare services also supports early diagnosis and treatment with ICD implantation.

Regulatory Support and Reimbursement Policies: Favorable regulatory frameworks and reimbursement policies in many countries facilitate access to ICD therapy. This encourages healthcare providers to prescribe ICDs and patients to undergo implantation procedures, boosting market growth.

Lifestyle Changes and Risk Factors: Changing lifestyles characterized by sedentary habits, unhealthy diets, and high-stress levels contribute to the prevalence of cardiovascular diseases. These lifestyle factors increase the risk of arrhythmias and sudden cardiac events, thereby driving the demand for ICDs as preventive and therapeutic interventions.

Technological Integration and Remote Monitoring: Integration of ICDs with advanced technologies, such as wireless connectivity and remote monitoring systems, improves patient management and enhances treatment outcomes. These features enable healthcare providers to monitor patients' cardiac health remotely, ensuring timely intervention and reducing healthcare costs associated with frequent clinic visits.

Key Challenges

High Cost: The cost of ICD devices and implantation procedures can be substantial, limiting access for patients in lower-income brackets and healthcare systems with budget constraints.

Technological Complexity: Despite advancements, the complexity of ICD technology requires specialized training for implantation and management, posing challenges for healthcare providers and increasing procedural risks.

Device Complications: ICDs may encounter complications such as lead dislodgement, infection at the implant site, and device malfunction. These issues can necessitate additional surgeries, impact patient outcomes, and increase healthcare costs.

Battery Life and Replacement: While battery technology has improved, ICDs still require periodic replacement due to battery depletion. This involves surgical procedures and associated risks, as well as costs.

Patient Selection and Management: Selecting appropriate candidates for ICD implantation and managing patients post-implantation require careful assessment of risks versus benefits. Factors such as age, comorbidities, and lifestyle choices influence patient outcomes and device effectiveness.

Regulatory Challenges: Adherence to regulatory requirements and ensuring compliance with evolving standards can be challenging for manufacturers and healthcare providers. Changes in regulatory frameworks may impact device approvals and market entry strategies.

Ethical Considerations: Ethical dilemmas may arise regarding appropriate patient selection, consent, and end-of-life care decisions for individuals with implanted devices designed to manage life-threatening conditions.

Competition and Market Dynamics: Intense competition among device manufacturers, coupled with market saturation in some regions, may pressure companies to innovate continuously while managing pricing and market share.

Key Trends:

Technological Advancements: Continuous innovation in ICD technology includes miniaturization, improved battery life, advanced algorithms for arrhythmia detection, and integration with digital health platforms for remote monitoring and patient management.

Shift towards Subcutaneous ICDs (S-ICDs): There is a growing preference for S-ICDs, which do not require leads to be placed inside the heart, reducing the risk of complications associated with transvenous leads. S-ICDs offer an alternative for patients with limited vascular access or higher risks of infection.

Personalized Medicine: Increasing focus on personalized treatment approaches drives the customization of ICD therapy based on patient-specific factors such as heart rhythm patterns, underlying conditions, and lifestyle considerations.

Enhanced Remote Monitoring and Connectivity: Integration of ICDs with wireless and mobile technologies enables real-time remote monitoring of cardiac rhythms and device function. This trend enhances patient care by facilitating early detection of arrhythmias and proactive management of device-related issues.

Growing Aging Population: The demographic shift towards an aging population contributes to a higher incidence of cardiovascular diseases and arrhythmias, increasing the demand for ICDs as a preventive and therapeutic solution.

Expansion of Indications: Broadening indications for ICD therapy beyond traditional primary and secondary prevention to include high-risk patients with non-ischemic cardiomyopathy and certain inherited arrhythmia syndromes expands the market potential.

Focus on Patient Outcomes: Emphasis on improving patient outcomes through comprehensive care pathways, including patient education, lifestyle modifications, and integrated management of cardiovascular health alongside ICD therapy.

Regulatory and Reimbursement Landscape: Evolving regulatory frameworks and reimbursement policies influence market dynamics, affecting device approvals, market access, and adoption rates across different regions.

Global Implantable Cardioverter Defibrillators Market Regional Analysis

Here is a more detailed regional analysis of the global implantable cardioverter defibrillators market:

North America

North America is significantly dominating the implantable cardioverter defibrillators market and is expected to continue its growth throughout the forecast period, owing to several variables. North America boasts a well-developed healthcare system with advanced medical facilities, including specialized cardiac centers and hospitals equipped to perform complex cardiac procedures such as ICD implantation.

The region has a notably high prevalence of cardiovascular diseases (CVDs), including coronary artery disease, heart failure, and arrhythmias. This high disease burden necessitates a robust market for cardiac devices like ICDs to manage and treat these conditions effectively.

North American companies are at the forefront of ICD innovation. They invest heavily in research and development (R&D) to enhance device capabilities, improve longevity, reduce complications, and incorporate advanced features such as remote monitoring and connectivity.

The regulatory environment in North America, particularly the United States through the FDA (Food and Drug Administration), facilitates efficient device approvals and market access. Clear regulatory pathways encourage innovation and expedite the introduction of new ICD technologies to the market.

The region benefits from a strong emphasis on biomedical research and innovation. Academic institutions, research centers, and private sector companies collaborate to drive advancements in cardiac care technologies, including ICDs.

Most North American countries have well-established healthcare insurance systems that provide broad coverage for medical devices and procedures, including ICD implantation. This ensures that eligible patients have access to ICD therapy without significant financial barriers.

Continuous medical education programs and professional development initiatives ensure that healthcare providers are well-trained in the latest ICD technologies and treatment protocols. This enhances patient care and contributes to high adoption rates of ICDs.

North American companies often have extensive global market presence and strategic partnerships with healthcare providers, distributors, and research institutions worldwide. This enables them to leverage economies of scale and effectively meet global demand for ICDs while maintaining technological leadership.

Asia Pacific

Asia Pacific is emerging as the fastest-growing region in the Implantable Cardioverter Defibrillators (ICD) market. The region is experiencing an increasing prevalence of cardiovascular diseases (CVDs) such as coronary artery disease and arrhythmias, driven by aging populations, sedentary lifestyles, and changing dietary habits.

Investments in healthcare infrastructure and expansion of specialized cardiac care facilities are improving access to advanced medical treatments, including ICD implantation.

Rising healthcare literacy and awareness about cardiovascular health are prompting earlier diagnosis and treatment of heart conditions, leading to higher demand for ICDs as life-saving devices.

Economic development and urbanization in countries across the Asia Pacific are contributing to lifestyle changes associated with higher CVD risk factors, such as obesity and hypertension, driving the need for cardiac interventions like ICDs.

The adoption of advanced medical technologies, including ICDs with improved battery life, smaller form factors, and enhanced functionalities, is increasing due to technological advancements and greater acceptance by healthcare providers and patients.

Supportive government policies, initiatives to enhance healthcare access, and efforts to strengthen regulatory frameworks for medical devices are facilitating market growth and improving patient outcomes.

Rising healthcare expenditure and expanding insurance coverage in many countries within the Asia Pacific are enabling more patients to afford ICD therapy, reducing financial barriers to treatment.

Collaboration between global medical device manufacturers, local healthcare providers, and distribution networks is accelerating market penetration and ensuring the availability of advanced cardiac care technologies across the region.

Global Implantable Cardioverter Defibrillators Market: Segmentation Analysis

The Global Implantable Cardioverter Defibrillators Market is segmented based on Type, Application, End User, And Geography.

Implantable Cardioverter Defibrillators Market, By Type

Single Chamber ICDs
Dual Chamber ICDs
Cardiac Resynchronization Therapy Defibrillators

Based on Type, the market is bifurcated into Single Chamber ICDs, Dual Chamber ICDs, Cardiac Resynchronization Therapy Defibrillators. The Dual Chamber ICDs segment dominates the market due to its ability to provide more accurate detection and treatment of arrhythmias compared to Single Chamber ICDs. Dual Chamber ICDs offer improved synchronization between the atrium and ventricle, enhancing therapeutic outcomes, especially in patients with complex arrhythmias requiring precise management.

Implantable Cardioverter Defibrillators Market, By Application

Ventricular Fibrillation
Arrhythmias

Based on Technology, the market is bifurcated into Ventricular Fibrillation, Arrhythmias. In the Implantable Cardioverter Defibrillators (ICD) market, the Ventricular Fibrillation (VF) application segment dominates. VF is a critical and life-threatening arrhythmia that can lead to sudden cardiac arrest. ICDs are specifically designed to detect and treat VF promptly, making them essential for preventing cardiac emergencies and improving patient survival rates in such cases.

Implantable Cardioverter Defibrillators Market, By End-User

Hospitals
Cardiac Centers
Ambulatory Surgical Centers

Based on End-Users the market is bifurcated into Hospitals, Cardiac Centers, Ambulatory Surgical Centers. In the Implantable Cardioverter Defibrillators (ICD) market, Hospitals dominate as the primary end-user segment. Hospitals possess specialized cardiac units, skilled healthcare professionals, and comprehensive infrastructure necessary for diagnosing, implanting, and managing ICDs. They offer a full spectrum of cardiac care services, making them the preferred choice for complex medical interventions like ICD implantation.

Implantable Cardioverter Defibrillators Market, By Geography

North America
Europe
Asia Pacific
Rest of the world

Based on Geography, the Global Implantable Cardioverter Defibrillators Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. Asia Pacific dominates the Implantable Cardioverter Defibrillators (ICD) market. This is due to factors such as advanced healthcare infrastructure, high prevalence of cardiovascular diseases, robust technological advancements, favorable reimbursement policies, and a proactive approach towards adopting innovative medical technologies, all contributing to greater market penetration and adoption rates in the region.

Key Players

The "Global Implantable Cardioverter Defibrillators Market" study report will provide valuable insight emphasizing the global market. The major players in the market are Medtronic, Abbott, Boston Scientific, Biotronik, LivaNova PLC, MicroPort Scientific Corporation, Koninklijke Philips N.V. (Philips Healthcare), ZOLL Medical Corporation, Medico S.p.A., Progetti Srl.

Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

Key Developments

In September 2022, Kauvery Hospital inaugurated the Restart Heart Foundation in Chennai, India, deploying more than 100 automated external defibrillators at strategic locations across the city.
In August 2022, Medtronic reported successful trial outcomes for its investigational EV ICD (extravascular implantable cardioverter defibrillator) system. This device is designed to mitigate certain risks associated with traditional transvenous ICDs by placing its lead outside the heart and veins, beneath the sternum, using a minimally invasive approach.